Corbus Pharmaceuticals Holdings (CRBP) Assets (2013 - 2025)

Corbus Pharmaceuticals Holdings has reported Assets for 13 years, with the latest figure at $168.2 million in Q4 2025.

• On a quarterly basis, Assets rose 7.9% year-over-year to $168.2 million in Q4 2025; TTM through Dec 2025 was $168.2 million, a 7.9% increase from a year earlier, with the FY2025 full-year figure at $168.2 million, up 7.9% from the prior year.
• Assets was $168.2 million for Q4 2025 at Corbus Pharmaceuticals Holdings, up from $109.5 million in the prior quarter.
• The five-year high for Assets was $168.2 million in Q4 2025, with the low at $28.3 million in Q4 2023.
• Average Assets over 5 years is $105.3 million, with a median of $114.5 million recorded in 2021.
• The sharpest annual moves came in 2023 and 2024: Assets sank 57.37% in 2023, then jumped 451.35% in 2024.
• Over 5 years, Assets stood at $107.7 million in 2021, then sank by 38.45% to $66.3 million in 2022, then tumbled by 57.37% to $28.3 million in 2023, then surged by 451.35% to $155.9 million in 2024, then rose by 7.9% to $168.2 million in 2025.
• The last three Assets figures came in at $168.2 million (Q4 2025), $109.5 million (Q3 2025), and $125.1 million (Q2 2025), per Business Quant data.